Gabexate or somatostatin administration before ERCP in patients at high rsik for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. - Andriulli,A.; Clemente,R.; Solmi,L.; Terruzzi,V.; Suriani,R.; Sigillito,A.; Leandro,G.; Leo,P.; De Maio,G.; Perri,F. (Gastrointest Endosc, 2002)